Physician profile
Matthew David Williams
NPI 1629084918
$235,053.10
in general payments reported to CMS, 2019-2025
41 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $6,208 · 2021: $27K · 2022: $39K · 2023: $46K · 2024: $30K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $105K · Food and Beverage: $6,874 · Consulting Fee: $6,833 · Travel and Lodging: $3,513 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105,485.00 |
| Food and Beverage | $6,873.73 |
| Consulting Fee | $6,832.50 |
| Travel and Lodging | $3,513.45 |
| Education | $130.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $198,289.29 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Genentech USA, INC. | $13,299.75 | 2019-2023 | Xolair, Tecentriq |
| Amgen INC. | $9,772.93 | 2021-2025 | Tezspire |
| Insmed, INC. | $6,370.45 | 2019-2025 | Arikayce |
| Glaxosmithkline, LLC. | $2,804.32 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $746.86 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $615.92 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.36 | 2019-2025 | Spiriva Respimat, Jascayd, Ofev |
| Mylan Specialty L.P. | $307.67 | 2019-2023 | Yupelri |
| Medtronic, INC. | $233.15 | 2024-2025 | Corevalve Evolut R |
| Takeda Pharmaceuticals U.S.A., INC. | $220.28 | 2022-2023 | Glassia |
| Electromed, INC. | $206.93 | 2019-2025 | Smartvest |
| Baxter Healthcare | $167.31 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Tela Bio, INC. | $151.83 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mallinckrodt Hospital Products INC. | $147.96 | 2022-2023 | Acthar |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $144.28 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $136.51 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $123.88 | 2019-2022 | |
| Inari Medical, INC. | $107.62 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| United Therapeutics Corporation | $80.72 | 2019-2023 | Tyvaso |
| Teva Pharmaceuticals USA, INC. | $70.81 | 2019-2023 | |
| Harmony Biosciences LLC | $55.07 | 2022-2023 | Wakix |
| Novartis Pharmaceuticals Corporation | $47.35 | 2019-2024 | |
| Pulmonx Corporation | $46.98 | 2023-2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Sanofi-Aventis U.S. LLC | $43.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.17 | 2019 | |
| Philips North America LLC | $39.11 | 2019-2022 | |
| Sanofi Pasteur INC. | $38.96 | 2019-2020 | |
| Astellas Pharma US INC | $36.81 | 2019-2022 | |
| Circassia INC. | $31.26 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.88 | 2019-2020 | |
| Grifols USA, LLC | $24.25 | 2023 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $23.73 | 2019 | |
| Inogen, INC. | $21.58 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ethicon US, LLC | $20.58 | 2022 | |
| Vapotherm INC | $18.65 | 2022 | |
| Verona Pharma, INC. | $18.47 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $17.31 | 2023 | Nuzyra |
| Shire North American Group INC | $15.42 | 2019 | |
| Merck Sharp & Dohme LLC | $12.91 | 2019 | |
| Pfizer INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.